Finally, we assessed the impact of HS3ST3B1, FMOD, CSPG4, ALDH1A1, CYP1B1, and ENO1 expression on the OS of patients with BLCA via univariate and multifactorial Cox regression analyses. This evidence concerns the gene CSPG4 and bladder transitional cell carcinoma.